Life Science Compliance Update

In the most recent chapter in the ongoing battle over the priority of patient assistance programs, the Caring Voice Coalition…

U.S. ex rel. Ruckh v. CMC II LLC et al. (“Ruckh”) was a closely followed False Claims Act case, because a Florida Federal Court…

In a closely watched matter culminating years of litigation, Medtronic on December 12, 2017, entered into a $12 Million…

As Life Science Compliance Update enters its fourth year of publication, it is a great pleasure to announce that Nicodemo…

For analyzing so-called “Big Data” sets, data analytics is an invaluable set of tools and techniques. Now the HHS OIG plans to…

To control rising costs under Medicare, the Affordable Care Act, and Medicare Access and CHIP Reauthorization Act of 2015…

Drug pricing transparency, as a concept at least, is here to stay. However, the details of what that means and the new obligations…

The issue of substandard and counterfeit medicines has been known for some time. Since it is not often discussed openly, it is…

In May 2018, the new European Union (“EU”) General Data Protection Regulation (“GDPR”) will replace the familiar Data Protection…

When we first introduced the FCPA Pilot Program in the June 2016 issue, we noted the uncertainties of outcomes for companies who…